Finance

Beta
Lists
023910:KOSDAQ
Dai Han Pharm Co Ltd
₩25,650.00
+0.98%
(+250.00) 1D
Jul 16, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 023910...
Open
₩25,400
High
₩25,700
Low
₩25,200
Mkt. cap
153.90B
Avg. vol.
11.51K
Volume
6.63K
Dividend
3.90%
Quarterly dividend
₩250
Ex-dividend date
Dec 29, 2021
P/E ratio
5.59
52-wk high
₩33,800
52-wk low
₩24,000
EPS
₩4,588
Shares outstanding
6.00M
No. of employees
737
Open
₩25,400
High
₩25,700
Low
₩25,200
Mkt. cap
153.90B
Avg. vol.
11.51K
Volume
6.63K
Dividend
3.90%
Quarterly dividend
₩250
Ex-dividend date
Dec 29, 2021
P/E ratio
5.59
52-wk high
₩33,800
52-wk low
₩24,000
EPS
₩4,588
Shares outstanding
6.00M
No. of employees
737
News stories
From sources across the web
About Dai Han Pharm Co Ltd
CEO-
Employees737
Founded1945
Headquarters-
SectorPharmaceutical industry
Websitedaihan.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
51.49B
56.17B
51.06B
52.71B
Cost of goods sold
35.49B
37.79B
38.11B
36.96B
Cost of revenue
35.49B
37.79B
38.11B
36.96B
Research and development expenses
485.25M
432.31M
614.41M
383.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.57B
7.09B
8.37B
7.33B
Operating expense
8.25B
7.75B
9.38B
7.89B
Total operating expenses
43.75B
45.54B
47.49B
44.85B
Operating income
7.75B
10.64B
3.57B
7.86B
Other non operating income
22.94M
-12.03M
16.84M
6.23M
EBT including unusual items
7.95B
11.23B
4.17B
8.79B
EBT excluding unusual items
7.75B
11.26B
4.18B
8.87B
Income tax expense
1.75B
2.52B
-903.43M
1.81B
Effective tax rate
21.98%
22.39%
-21.65%
20.57%
Other operating expenses
35.71M
97.88M
273.08M
52.18M
Net income
6.20B
8.72B
5.08B
6.98B
Net profit margin
12.05%
15.52%
9.94%
13.24%
Earnings per share
-
-
-
-
Interest and investment income
454.00M
478.34M
526.28M
502.90M
Interest expense
-623.39K
-722.02K
-819.90K
-321.13K
Net interest expenses
453.37M
477.61M
525.46M
502.58M
Depreciation and amortization charges
147.02M
139.32M
140.33M
140.63M
EBITDA
9.74B
13.11B
6.50B
10.96B
Gain or loss from assets sale
-19.39M
-2.00M
3.00K
-13.64M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more